10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x           QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ending September 30, 2012

¨           TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 0-11102

OCEAN BIO-CHEM, INC.

(Exact name of registrant as specified in its charter)

Florida	59-1564329
(State Or Other Jurisdiction Of Incorporation Or Organization)	(I.R.S. Employer Identification No.)

4041 SW 47 AVENUE

FORT LAUDERDALE, FLORIDA  33314

(Address of principal executive offices)

954-587-6280

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x     No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer    ¨	Accelerated filer    ¨
Non-accelerated filer    ¨	Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes  ¨    No  x

At November 14, 2012, 8,299,763 shares of the registrant’s Common Stock were outstanding.

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

		Page
PART I	Financial Information:
	Item 1. Financial Statements
	Condensed consolidated balance sheets at September 30, 2012 (unaudited) and December 31, 2011	3
	Condensed consolidated statements of operations (unaudited) for the three and nine months ended September 30, 2012 and 2011	4
	Condensed consolidated statements of comprehensive income (unaudited) for the three and nine months ended September 30, 2012 and 2011	5
	Condensed consolidated statements of cash flows (unaudited) for the nine months ended September 30, 2012 and 2011	6
	Notes to condensed consolidated financial statements	7-12
	Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	13-16
	Item 3. Quantitative and Qualitative Disclosures about Market Risk	16
	Item 4. Controls and Procedures	17
PART II	Other Information:
	Item 1A. Risk Factors	17
	Item 6. Exhibits	17
	Signatures	18

2

PART 1-FINANCIAL INFORMATION

Item 1. Financial Statements

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

	September 30,  2012			December 31, 2011
	(Unaudited)
ASSETS
Current Assets:
Cash	$	775,399		$	585,357
Trade accounts receivable net of allowance for doubtful accounts of approximately $135,000 and $75,000 at September 30, 2012 and December 31, 2011, respectively		5,912,093			2,563,089
Receivables due from affiliated companies		335,746			495,130
Inventories, net		9,535,285			9,627,798
Prepaid expenses and other current assets		536,621			424,168
Deferred tax asset		134,030			65,797
Total Current Assets		17,229,174			13,761,339
Property, plant and equipment, net		5,100,690			5,213,333
Other Assets:
Trademarks, trade names and patents, net		832,056			870,642
Other assets		25,591			33,442
Total Other Assets		857,647			904,084
Total Assets	$	23,187,511		$	19,878,756
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Accounts payable – trade	$	2,274,721		$	1,162,143
Revolving line of credit		1,700,000			850,000
Current portion of long term debt		404,271			400,430
Income taxes payable		33,381			353,608
Accrued expenses payable		980,370			889,444
Total Current Liabilities		5,392,743			3,655,625
Deferred tax liability		296,351			250,191
Long term debt, less current portion		1,634,906			1,939,362
Total Liabilities		7,324,000			5,845,178
Commitments and contingencies
Shareholders' Equity:
Common stock - $.01 par value, 12,000,000 shares authorized; 8,640,116 and 8,458,389 shares issued at September 30, 2012 and December 31, 2011, respectively		86,401			84,584
Additional paid in capital		8,516,870			8,163,864
Less cost of common stock in treasury, 351,503 shares at September 30, 2012 and December 31, 2011, respectively		(288,013	)		(288,013	)
Foreign currency translation adjustment		(261,728	)		(268,084	)
Retained earnings		7,556,770			6,058,848
Total Shareholders' Equity of Ocean Bio-Chem, Inc.		15,610,300			13,751,199
Noncontrolling interest		253,211			282,379
Total Shareholders' Equity		15,863,511			14,033,578
Total Liabilities and Shareholders' Equity	$	23,187,511		$	19,878,756

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 

3

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2012			2011			2012			2011
Gross sales	$	10,750,275		$	10,429,694		$	25,446,178		$	26,184,476
Less: discounts, returns, and allowances		488,413			545,643			1,297,936			1,349,944
Net sales		10,261,862			9,884,051			24,148,242			24,834,532
Cost of goods sold		6,997,495			6,538,236			15,877,264			16,002,122
Gross profit		3,264,367			3,345,815			8,270,978			8,832,410
Operating Expenses:
Advertising and promotion		783,523			476,366			1,890,438			1,506,145
Selling and administrative		1,305,613			1,241,053			3,964,994			4,017,667
Total operating expenses		2,089,136			1,717,419			5,855,432			5,523,812
Operating income		1,175,231			1,628,396			2,415,546			3,308,598
Other income (expense)
Interest expense		(22,138	)		(34,835	)		(75,586	)		(108,054	)
Other (expense) income		(3,449	)		13,227			(627	)		38,738
Income before income taxes		1,149,644			1,606,788			2,339,333			3,239,282
Provision for income taxes		388,755			478,649			870,579			1,106,617
Net income		760,889			1,128,139			1,468,754			2,132,665
Loss attributable to noncontrolling interests		9,729			9,546			29,168			42,717
Net income attributable to Ocean Bio-Chem, Inc.	$	770,618		$	1,137,685		$	1,497,922		$	2,175,382
Earnings per common share – basic	$	0.09		$	0.14		$	0.18		$	0.27
Earnings per common share – diluted	$	0.09		$	0.13		$	0.18		$	0.26
Weighted average shares - basic		8,288,613			7,997,613			8,201,376			7,916,932
Weighted average shares - diluted		8,595,506			8,537,806			8,540,777			8,394,413

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 

4

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(UNAUDITED)

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2012		2011			2012		2011
Net Income	$	760,889	$	1,128,139		$	1,468,754	$	2,132,665
Foreign currency translation adjustment		6,838		(3,759	)		6,356		212
Comprehensive income		767,727		1,124,380			1,475,110		2,132,877
Comprehensive loss attributable to noncontrolling interests		9,729		9,546			29,168		42,717
Comprehensive income attributable to Ocean Bio-Chem, Inc.	$	777,456	$	1,133,926		$	1,504,278	$	2,175,594

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	Nine Months Ended
	September 30,
	2012			2011
Cash flows from operating activities:
Net income	$	1,468,754		$	2,132,665
Adjustments to reconcile net income to net cash used in operating activities
Depreciation and amortization		522,499			584,625
Deferred income taxes		(22,073	)		160,482
Stock based compensation		267,477			388,866
Other operating non-cash items		87,654			122,462
Changes in assets and liabilities:
Trade accounts receivable		(3,409,339	)		(3,291,494	)
Inventories		83,478			(2,967,069	)
Other assets		7,851			10,943
Prepaid expenses and other current assets		(112,453	)		(182,728	)
Receivables due from affiliated companies		159,384			23,312
Accounts payable and other accrued expenses		883,277			1,114,769
Net cash used in operating activities		(63,491	)		(1,903,167	)
Cash flows from investing activities:
Purchases of property, plant and equipment		(374,428	)		(313,276	)
Contributions  from joint venture		-			36,842
Net cash used in investing activities		(374,428	)		(276,434	)
Cash flows from financing activities:
Net borrowings under revolving line of credit		850,000			3,400,000
Proceeds from issuance of long term debt		-			2,430,000
Repayments of notes payable related party		-			(471,950	)
Payments on long-term debt		(300,615	)		(2,988,581	)
Proceeds from exercise of stock options		78,020			6,300
Net cash provided by financing activities		627,405			2,375,769
Effect of exchange rates on cash		556			(1,950	)
Net increase in cash		190,042			194,218
Cash at beginning of period		585,357			615,044
Cash at end of period	$	775,399		$	809,262
Supplemental disclosure of cash transactions:
Cash paid for interest during period	$	76,203		$	118,594
Cash paid for income taxes during period	$	1,212,879		$	1,259,000

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6

OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. SUMMARY OF ACCOUNTING POLICIES

Interim reporting

The accompanying unaudited condensed consolidated financial statements include the accounts of Ocean Bio-Chem, Inc. and its subsidiaries, all of which are wholly-owned, and OdorStar Technology LLC (“OdorStar”), a joint venture in which the Company has a controlling interest.  All significant intercompany transactions and balances have been eliminated in consolidation.  Certain prior-period data have been reclassified to conform to the current period presentation.  Unless the context indicates otherwise, the term “Company” refers to Ocean Bio-Chem, Inc. and its subsidiaries

The unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.

The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods.  The results of operations for the three and nine months ended September 30, 2012 are not necessarily indicative of the results to be expected for the year ending December 31, 2012.

The information included in this Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2011.

Use of estimates

The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates and assumptions.

Subsequent events

The Company evaluates events through the date the financial statements are filed to determine whether such events require adjustment to or disclosure in the financial statements.

2. RECENT ACCOUNTING PRONOUNCEMENTS

There have been no accounting pronouncements or changes in accounting pronouncements during the nine months ended September 30, 2012 that are expected to have a material impact on the Company’s financial position, results of operations or cash flows.  Accounting pronouncements that became effective during the nine months ended September 30, 2012 did not have a material impact on disclosures or on the Company’s financial position, results of operations or cash flows.

7

3. INVENTORIES

The composition of inventories at September 30, 2012 and December 31, 2011 are as follows:

	September 30, 2012			December 31, 2011
Raw materials	$	4,448,470		$	4,431,651
Finished goods		5,372,553			5,472,850
Inventories, gross		9,821,023			9,904,501
Inventory reserves		(285,738	)		(276,703	)
Inventories, net	$	9,535,285		$	9,627,798

The inventory reserves shown in the table above reflect slow moving and obsolete inventory.

The Company operates a vendor managed inventory program with one of its customers to improve the promotion of the Company's products.  The Company manages the inventory levels at this customer’s warehouses and recognizes revenue as the products are sold by the customer.  The inventories managed at the customer’s warehouses amounted to approximately $548,000 and $570,000 at September 30, 2012 and December 31, 2011, respectively.

4. PROPERTY, PLANT, & EQUIPMENT

The Company’s property, plant and equipment consisted of the following at September 30, 2012 and December 31, 2011:

	Estimate Useful Life	September 30,  2012			December 31, 2011
Land		$	278,325		$	278,325
Building and improvements	30 years		4,487,267			4,445,924
Manufacturing and warehouse equipment	6-20 years		7,918,239			7,632,398
Office equipment and furniture	3-5 years		703,537			668,046
Construction in process			31,207			32,788
Leasehold improvements	10-15 years		122,644			122,644
Property, plant and equipment, gross			13,541,219			13,180,125
Less accumulated depreciation			(8,440,529	)		(7,966,792	)
Property, plant and equipment, net		$	5,100,690		$	5,213,333

5. NONCONTROLLING INTEREST

On May 10, 2010, the Company and BBL Distributors, LLC formed OdorStar. OdorStar owns patents that relate to a formula and delivery system, for use with products containing chlorine dioxide, designed to safely prevent and eliminate odors relating to mold, mildew and other sources of unpleasant odors.  The Company and BBL Distributors, LLC share equally in profits or losses from OdorStar.  Because the Company manages OdorStar, it has consolidated OdorStar in its financial statements.  The Company’s condensed consolidated financial statements include approximately $507,000 and $541,000 in assets and $7,000 and $6,000 in liabilities from OdorStar at September 30, 2012 and December 31, 2011, respectively.  The Company’s condensed consolidated financial statements also include OdorStar’s operating losses of approximately $19,000 and $19,000 during the three months ended September 30, 2012 and 2011, respectively, and $58,000 and $85,000 during the nine months ended September 30, 2012 and 2011, respectively.

8

6. REVOLVING LINE OF CREDIT

On July 6, 2011, the Company, together with its subsidiary, Kinpak Inc. (“Kinpak”), entered into a Credit Agreement with Regions Bank (and, pursuant to an Equipment Finance Addendum to the Credit Agreement, Regions Equipment Finance Corporation (“REFCO”)).  Under the Credit Agreement, the Company’s revolving line of credit with Regions Bank was renewed.  The terms of the revolving line of credit, as renewed, provide that the Company may borrow up to the lesser of (i) $6 million or (ii) a borrowing base equal to 80% of eligible accounts receivable plus 50% of eligible inventory.  Interest on the revolving line of credit is payable at the 30 day LIBOR rate plus 1.74% per annum (unless the Company’s debt service coverage ratio (net profit plus taxes, interest, depreciation, amortization and rent expense divided by debt service plus interest and lease/rent expense) falls below 2.0 to 1, in which case the interest is payable at the 30 day LIBOR rate plus 2.75% per annum).  In no event will the interest rate be less than 2.0% per annum.  Outstanding amounts under the revolving line of credit are payable on demand.  If no demand is made, the Company may repay and reborrow funds from time to time.  The Company’s obligations under the revolving line of credit are secured by the Company’s accounts receivable and inventory, as well as real property and equipment at Kinpak’s Montgomery, Alabama facility. The Company’s obligations under the revolving line of credit and the term loan discussed in footnote 7 below are cross-collateralized.  Interest on amounts borrowed under the revolving line of credit is payable in monthly installments on outstanding average balances, with all outstanding principal and interest payable on July 6, 2014.  The Credit Agreement includes financial covenants requiring a minimum debt service coverage ratio of 1.75 to 1.00, tested on a rolling four-quarter basis, and a maximum debt to capitalization ratio (funded debt divided by the sum of total net worth and funded debt) of 0.75 to 1, tested quarterly.  At September 30, 2012, the Company was in compliance with these covenants. The Company’s principal obligations under the revolving line of credit were $1,700,000 and $850,000 at September 30, 2012 and December 31, 2011, respectively.  The interest rate was 2.0% per annum at September 30, 2012 and December 31, 2011.

7. LONG TERM DEBT

On July 6, 2011, under the Equipment Finance Addendum to the Credit Agreement, REFCO provided to the Company a $2,430,000 term loan with a fixed interest rate of 3.54%.  Principal and interest on the term loan are payable in equal monthly installments through July 6, 2017, the date on which the term loan matures.  The proceeds of the term loan were used to pay the Company’s remaining obligations under a lease agreement relating to industrial revenue bonds used to fund the expansion of Kinpak’s facilities and acquisition of related equipment.  At September 30, 2012, approximately $1,997,000 was outstanding under the term loan.

At September 30, 2012 and December 31, 2011, the Company was obligated under various capital lease agreements covering equipment utilized in the Company’s operations.  The capital leases, aggregating $42,209 and $62,400 at September 30, 2012 and December 31, 2011, respectively, have varying maturities through 2015 and carry interest rates ranging from 7% to 14%.

The following table provides information regarding the Company’s long term debt at September 30, 2012 and December 31, 2011:

	Current Portion				Long Term Portion
	September 30,  2012		December 31, 2011		September 30,  2012		December 31, 2011
Term loan		385,652		375,562		1,611,316		1,901,830
Capitalized equipment leases		18,619		24,868		23,590		37,532
Total long term debt	$	404,271	$	400,430	$	1,634,906	$	1,939,362

9

Required principal payments under the Company’s long term obligations are set forth below:

12 month period ending September 30,
2013	$	404,271
2014		412,786
2015		423,384
2016		429,645
2017		369,091
Total	$	2,039,177

8. RELATED PARTY TRANSACTIONS

During the three and nine months ended September 30, 2012 and 2011, the Company sold products to companies affiliated with its Chairman, President and Chief Executive Officer. The affiliated companies distribute the products outside of the United States and Canada. The Company also provides administrative services to these companies. Sales to the affiliated companies aggregated approximately $386,000 and $325,000during the three months ended September 30, 2012 and 2011, respectively, and $997,000 and $1,159,000for the nine months ended September 30, 2012 and 2011, respectively.  Administrative fees aggregated approximately $70,000 and $78,000during the three months ended September 30, 2012 and 2011, respectively, and $216,000 and $178,000for the nine months ended September 30, 2012 and 2011, respectively.  The Company had accounts receivable from the affiliated companies in connection with the product sales and administrative services aggregating approximately $336,000 and $495,000 at September 30, 2012 and December 31, 2011, respectively. Transactions with the affiliated companies were made in the ordinary course of business.   While the terms of sale to the affiliated companies differ from other customers, the affiliated companies bear their own warehousing, distribution, advertising, selling and marketing costs, as well as their own freight charges (the company pays freight charges in connection with sales to its domestic customers on all but small orders).  Moreover, the Company does not pay sales commissions with respect to products sold to the affiliated companies.  As a result, the Company believes its profit margins with respect to sales to the affiliated companies are similar to the profit margins with respect to sales to its larger domestic customers. 

A subsidiary of the Company currently uses the services of an entity that is owned by the Chairman, President and Chief Executive Officer of the Company to conduct product research and development, marketing and advertising.  The Company paid the entity approximately $10,500 for each of the three month periods ended September 30, 2012 and 2011, and $31,500 for each of the nine month periods ended September 30, 2012 and 2011, under this arrangement.

The Company leases office and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer.  The Company believes that the rental payments are below market rates.  See Note 9 for a description of the lease terms.

On December 6, 2010, the Company redeemed a warrant held by its Chairman, President and Chief Executive Officer to purchase 500,000 shares of its Common Stock at an exercise price of $0.836 per share.  The warrant initially was issued to him in connection with financing he provided to the Company in December 2005.  The aggregate redemption price of the warrant was $471,950, which was based on the difference between the closing price of the Company's Common Stock on December 6, 2010 and the exercise price of the warrant.  The Company issued a note to the Chairman, President and Chief Executive Officer in an amount equal to the redemption price, which bore interest at the rate of 3% per annum.  On January 5, 2011, the Company paid all outstanding principal and interest on the note.  The redemption, which was approved by the independent directors of the Board of Directors, was effected in order to prevent the dilutive effect of the exercise of the warrant.

A director of the Company is Regional Executive Vice President of an entity from which the Company sources most of its insurance needs at an arm’s length competitive basis.  During the three months ended September 30, 2012 and 2011, the Company paid an aggregate of approximately $171,000 and $304,000, respectively, and during the nine months ended September 30, 2012 and 2011, the Company paid an aggregate of approximately $443,000 and $528,000 respectively, in insurance premiums on policies obtained through the entity.

10

9. COMMITMENTS

The Company leases its executive offices and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer. On May 1, 2008, the Company renewed the lease for a term of ten years. The lease requires annual minimum base rent of $94,800 and provides for a maximum annual 2% increase in subsequent years, although the entity has not raised the minimum rent since the Company entered into the initial lease agreement in 1998. Additionally, the leasing entity is entitled to reimbursement of all taxes, assessments, and any other expenses that arise from ownership. Each of the parties to the lease has agreed to review the terms of the lease every three years at the request of the other party.  Rent expense under the lease was approximately $24,000 for each of the three month periods ended September 30, 2012 and 2011, and was approximately $73,000 for each ofthe nine month periods ended September 30, 2012 and 2011.

The Company leases from the Alabama State Port Authority a 1.5 acre docking facility on the Alabama River, located approximately eleven miles from the Company’s Alabama manufacturing facility.  The lease expires on September 30, 2014, and requires the Company to pay rent and additional expenses totaling approximately $7,800 annually.

10. EARNINGS PER SHARE

Basic earnings per share is calculated based on net income attributable to Ocean Bio-Chem, Inc. and the weighted average number of shares outstanding during the reported period.  Diluted earnings per share reflect additional dilution from potential common stock issuable upon the exercise of outstanding stock options.  The following table sets forth the computation of basic and diluted earnings per common share, as well as a reconciliation of the weighted average number of common shares outstanding to the weighted average number of shares outstanding on a diluted basis.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012		2011
Earnings per common share -Basic
Net income attributable to OBCI	$	770,618	$	1,137,685	$	1,497,922	$	2,175,382
Weighted average number of common shares outstanding		8,288,613		7,997,613		8,201,376		7,916,932
Earnings per common share - Basic	$	0.09	$	0.14	$	0.18	$	0.27
Earnings per common share – Diluted
Net income attributable to OBCI	$	770,618	$	1,137,685	$	1,497,922	$	2,175,382
Weighted average number of common shares outstanding		8,288,613		7,997,613		8,201,376		7,916,932
Effect of employee stock-based awards		306,893		540,193		339,401		477,481
Weighted average number of common shares outstanding - assuming dilution		8,595,506		8,537,806		8,540,777		8,394,413
Earnings per common share - Diluted	$	0.09	$	0.13	$	0.18	$	0.26

The Company had no stock options outstanding for the three and nine months ended September 30, 2012 and 2011, respectively, that were anti-dilutive and therefore not included in the diluted earnings per common share calculation.

11

11.  SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

On May 9, 2012, the Company issued stock awards covering 117,000 shares of common stock under its 2011 Omnibus Equity Compensation Plan. The Company recognized compensation expense based upon the average of the high and low trading price of its common stock on the issuance date.

On May 17, 2012, stock options with respect to 132,800 shares were exercised, and options related to 6,500 shares expired. Following the surrender of 68,073 shares in connection with a net exercise feature of the stock options, the Company issued an aggregate of 64,727 shares.

There was no stock compensation expense related to stockawards during the three months ended September 30, 2012 and 2011.  Non cash stock based compensation recognized during the nine months ended September 30, 2012 and 2011 attributable to stock awards totaled approximately $223,000 and $321,000, respectively.  Non cash stock compensation expense attributable to stock options was approximately $10,000 and $23,000 for the three months ended September 30, 2012 and 2011, respectively.  Non cash stock compensation expense attributable to stock options was approximately $44,000 and $68,000 for the nine months ended September 30, 2012 and 2011, respectively.

At September 30, 2012, there was approximately $22,000 of unrecognized compensation expense related to stockoptions awarded to employees.  This cost will be charged as compensation expense through 2013, as the stock options vest.

The following table provides information at September 30, 2012 regarding outstandingstock options under the Company’s stock option plans as well as a grant made outside of the Company’s stock option plans. As used in the table below, “2007 ISO” refers to the Company’s 2007 Incentive Stock Option Plan, “2008 ISO” refers to the Company’s 2008 Incentive Stock Option Plan, “2002 NQ” refers to the Company’s 2002 Non-Qualified Stock Option Plan and “2008 NQ” refers to the Company’s 2008 Non-Qualified Stock Option Plan.

Plan	Date Granted	Options Outstanding		Exercisable Options	Exercise Price		Expiration Date	Weighted Average Remaining Life
Non Plan	3/25/09		115,000	115,000	$	0.55	3/24/14	1.5
2007 ISO	10/08/07		2,500	2,000		1.87	10/07/12	0.0
2007 ISO	12/17/07		141,000	109,700		1.32	12/16/12	0.2
2008 ISO	8/25/08		142,900	108,880		0.97	8/24/13	0.9
2002NQ	10/22/02		30,000	30,000		1.26	10/21/12	0.1
2002NQ	6/20/03		30,000	30,000		1.03	6/19/13	0.7
2002NQ	5/25/04		30,000	30,000		1.46	5/24/14	1.7
2002NQ	4/03/06		40,000	40,000		1.08	4/02/16	3.6
2002NQ	12/17/07		50,000	50,000		1.32	12/16/17	5.3
2008NQ	1/11/09		50,000	50,000		0.69	1/10/19	6.4
2008NQ	4/26/10		25,000	25,000		2.07	4/25/20	7.7
			656,400	590,580	$	1.07		2.0

12

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-looking Statements:

Certain statements contained in this Quarterly Report on Form 10-Q, including without limitation, advertising and promotion expense, our ability to provide required capital to support inventory levels, the effect of price increases in petroleum-based or chemical-based raw materials on our margins, and the sufficiency of funds provided through operations and existing sources of financing to satisfy our cash requirements constitute forward-looking statements.  For this purpose, any statements contained in this report that are not statements of historical fact may be deemed forward-looking statements.  Without limiting the generality of the foregoing, words such as "believe," "may," "will," "expect," "anticipate," "intend," or "could," including the negative or other variations thereof or comparable terminology, are intended to identify forward-looking statements.  These statements involve known and unknown risks, uncertainties and other factors which may cause actual results to be materially different from those expressed or implied by such forward-looking statements.  Factors that may affect these results include, but are not limited to, the highly competitive nature of our industry, reliance on certain key customers, changes in consumer demand for marine, recreational vehicle and automotive products, advertising and promotional efforts, exposure to market risks relating to changes in interest rates and foreign exchange rates, and other factors.

Overview:

We are principally engaged in manufacturing, marketing and  distributinga broad line of appearance and maintenance products for boats, recreational vehicles, automobiles and home care under the Star brite® and other trademarks within the United States of America and Canada.  In addition, we produce private label formulations of many of our products for various customers and provide custom blending and packaging services for these and other products.  We sell our products through national retailers and to national and regional distributors who, in turn, sell our products to specialized retail outlets.

Critical accounting estimates:

See “Management's Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Estimates" in Part II, Item 7 of the Company's Annual Report on Form 10-K for the year ended December 31, 2011 for information regarding the Company's critical accounting estimates.

Results of Operations:

Three Months Ended September 30, 2012 Compared to the Three Months Ended September 30, 2011

Net sales were approximately $10,262,000 for the three months ended September 30, 2012 compared to approximately $9,884,000 during the corresponding period in 2011, an increase of $378,000 or 3.8%.  The increase in sales primarily reflected increased sales of winterizing products (antifreeze)  to marine customers.  In addition, we continued to realize sales growth of our enzyme fuel treatment product, Star Tron®, into the automotive and small engine markets.  These increases were partially offset by decreased sales to some of our largest customers as a result of their continuation of inventory reduction programs in our sector during the third quarter of 2012.

Cost of goods sold and gross profit – Cost of goods sold increased by approximately $459,000 or 7.0% to approximately $6,997,000 during the three months ended September 30, 2012, from approximately $6,538,000 during the same period in 2011.  We had a higher mix of lower margin sales of antifreeze in the third quarter 2012 compared to the comparative quarter 2011.  In addition, the allocation of fixed manufacturing costs over our lower inventory levels, as a result of our planned inventory reduction, led to higher per unit costs of sales.  Inventories at September 30, 2012 were $9,535,000 compared to $10,660,000 at September 30, 2011, a decrease of $1,125,000.  The increase in cost of goods sold also reflects our increased sales volume.

Gross profit decreased by approximately $81,000 for the three months ended September 30, 2012, as compared to the same period in 2011, as a the result of the factors described above.

13

Advertising and promotion expenses increased to approximately $783,000 for the three months ended September 30, 2012 from $476,000 during the corresponding period in 2011, an increase of approximately $307,000 or 64.5%.  As a percentage of net sales, advertising and promotion expense was approximately 7.6% in the third quarter of 2012 compared to approximately 4.8% in the third quarter of 2011.   The increase in advertising expenditures was designed to increase consumer awareness of Star Tron® products into new markets, including automotive, power sports, motorcycle, small engine and outdoor power equipment markets.  We sponsored several television programs and purchased print advertisements in several national magazines targeted to automotive, boating and engine maintenance and repair enthusiasts, as well as in specific industry magazines.  In addition, we increased expenditures for customer cooperative advertising allowances to promote our Star Tron and Star brite products in their sales promotion flyers.

Selling and administrative expenses increased by approximately $65,000 or 5.2%, from approximately $1,241,000 during the three months ended September 30, 2011 to approximately $1,306,000 during the same period in 2012.   The increase in expenses was directly attributable to the Company’s selling activities, including travel and entertainment expenses and an increase in the allowance for doubtful accounts, reflecting increased accounts receivable balances.  As a percentage of net sales, selling and administrative expenses were 12.7% and 12.6% for the third quarter of 2012 and 2011, respectively.

Interest expense decreased by approximately $13,000 to approximately $22,000 during the three months ended September 30, 2012, compared to approximately $35,000 during the three months ended September 30, 2011. The decrease reflects the lower average borrowings as a result of decreased inventory levels.

Operating income – As a result of the foregoing, operating income was approximately $1,175,000 in the third quarter of 2012 compared to approximately $1,628,000 in the 2011 period, a decrease of $453,000 or 27.8% predominately as a result of lower gross margins and higher advertising spending.

Income taxes - We had income tax expense in the third quarter of 2012 of approximately $389,000, or 33.8% of pretax income, compared to approximately $479,000, or 29.8% of pretax income, during the corresponding period in 2011.  The lower 2011 income tax rate reflects a one time benefit related to state income taxes.

Net income and Net income attributable to Ocean Bio-Chem, Inc. - As a result of the items mentioned above, net income for the third quarter of 2012 decreased by approximately $367,000, or 32.6%, to $761,000 from approximately $1,128,000 in the third quarter of 2011.  Net income attributable to Ocean Bio-Chem. Inc. decreased by approximately $367,000, or 32.3%, to $771,000 in the third quarter 2012, from approximately $1,138,000 in 2011.

Nine Months Ended September 30, 2012 Compared to the Nine Months Ended September 30, 2011

Net sales were approximately $24,148,000 for the nine months ended September 30, 2012 compared to approximately $24,834,000 during the corresponding period in 2011, a decrease of $686,000 or 2.8%.  We believe the sales decrease principally reflects a determination by some of our largest customers to reduce their inventory levels in our sector.   This decrease was partially offset by increased sales of winterizing products (antifreeze), as described above in the discussion of results for the three months ended September 30, 2012.

Cost of goods sold and gross profit – Our gross profit percentage (gross profit as a percentage of net sales) decreased by 1.3% in the first nine months of 2012 as compared to the same period in 2011.   The decrease reflects increased per unit cost of sales, as a result of our planned inventory reduction that is described in the discussion of results for the three months ended September 30, 2012, as well as lower sales volumes.  In addition, the decrease reflects the higher mix of lower margin products (antifreeze).

Advertising and promotion expenses increased to approximately $1,890,000 for the nine months ended September 30, 2012 from approximately $1,506,000 during the corresponding period in 2011, an increase of approximately $384,000 or 25.5%.  As a percentage of net sales, advertising and promotion expense increased from 6.1% during the nine months of 2011 to 7.8% in the nine months of 2012.  The significant year to date increase occurred in the third quarter and reflected the factors addressed above in the discussion of results for the quarter ended September 30, 2012.

Selling and administrative expenses decreased by approximately $53,000 or 1.3%, from approximately $4,018,000 during the nine months ended September 30, 2011 to approximately $3,965,000 during the same period in 2012.  The decrease is due to decreased non-cash stock-based compensation.  As a percentage of net sales, selling and administrative expenses increased from 16.2% to 16.4% due to lower year to date sales.

14

Interest expense decreased by approximately $32,000 to $76,000 during the nine months ended September 30, 2012, compared to approximately $108,000 during the nine months ended September 30, 2011. The decrease reflects the impact of the July 2011 refinancing of both our short term borrowing and long term debt at lower interest rates, as well as lower average borrowings as a result of lower average monthly inventory levels.

Operating income – As a result of the foregoing, operating income was approximately $2,416,000 in the first nine months of 2012 compared to approximately $3,309,000 in the 2011 period, a decrease of $893,000 or 27.0%.

Income taxes - The Company had income tax expense in the first nine months of 2012 of approximately $871,000, or 37.2% of pretax income, compared to approximately $1,107,000, or 34.2% of pretax income, during the corresponding period in 2011.  The lower 2011 income tax rate reflects a one time benefit related to state income taxes.

Net income and Net income attributable to Ocean Bio-Chem, Inc. - As a result of the items mentioned above, net income for the first nine months of 2012 decreased by approximately $664,000, or 31.1%, to $1,469,000 from approximately $2,133,000 during the corresponding period in 2011.  Net income attributable to Ocean Bio-Chem. Inc. decreased by approximately $677,000, or 31.1%, to $1,498,000 in the first nine months of 2012, from approximately $2,175,000 in 2011.

Liquidity and capital resources:

Our cash balance was approximately $775,000 at September 30, 2012 compared to approximately $585,000 at December 31, 2011.  At September 30, 2012, we had $1,700,000 in short-term borrowings outstanding under our revolving line of credit compared to $850,000 outstanding at December 31, 2011.

Net cash used in operating activities during the nine months ended September 30, 2012 was approximately $63,000 compared to net cash used in operating activities of approximately $1,903,000 for the nine months ended September 30, 2011.   The improvement reflects our inventory management efforts.  During the nine months ended September 30, 2011, we increased inventory by approximately $2,967,000 in anticipation of higher petroleum prices, and higher seasonal sales of winterizing products.  During the nine months ended September 30, 2012, we determined to modestly reduce inventory levels, particularly due to decreased purchases by some of our largest customers which, as noted above, are engaged in inventory reduction programs.  We reduced inventory levels by approximately $83,000 during the nine months ending September 30, 2012, and by approximately $1,125,000 as compared to September 30, 2011.  These cash flow improvements were partially offset by lower net income and lower non-cash charges.

Net cash used in investing activities was approximately $374,000 for the nine months ended September 30, 2012 compared to approximately $276,000 for the nine months ended September 30, 2011.  We continue to invest in our manufacturing facilities as we deem appropriate.

Net cash provided by financing activities was approximately $627,000 for the nine months ended September 30, 2012 compared to net cash provided of approximately $2,376,000 during the nine months ended September 30, 2011.  During the nine months ended September 30, 2012, we borrowed $850,000 under our revolving line of credit, and received approximately $78,000 from the exercise of stock options, which was partially offset by approximately $301,000 used forscheduled payments of principal on our long-term debt.  During the first nine months of 2011 we borrowed  $3,400,000 on our revolving line of credit.

Under the credit agreement among us, our subsidiary, Kinpak, Inc. and Regions Bank (and, pursuant to an Equipment Finance Addendum to the Credit Agreement, Regions Equipment Finance Corporation (“REFCO”)), we have borrowings under a term loan, which is payable,  together with interest at the fixed rate of 3.54% per annum, in 72 consecutive monthly payments of $37,511,  with the final payment on July 6, 2017. At September 30, 2012, the remaining principal balance on the term loan was $1,996,968. In addition, the credit agreement provides for a revolving line of credit, under which we may borrow up to the lesser of (i) $6 million and (ii) a borrowing base equal to 80% of eligible accounts receivable plus 50% of eligible inventory. Interest on the revolving line of credit is payable at the 30 day LIBOR rate plus 1.74% per annum (unless our debt service coverage ratio (net profit plus taxes, interest, depreciation, amortization and rent expense divided by debt service plus interest and lease/rent expense) falls below 2.0 to 1, in which case interest will be payable at the 30 day LIBOR rate plus 2.75% per annum). In no event will the interest rate be less than 2.0% per annum. Outstanding amounts under the revolving line of credit are payable on demand.  If no demand is made, we may repay and reborrow funds from time to time.

15

Interest on amounts borrowed under the revolving line of credit is payable in monthly installments on outstanding average balances, with all outstanding principal and interest payable on July 6, 2014.  At September 30, 2012, the outstanding balance under the revolving line of credit was $1,700,000.

The Credit Agreement contains various covenants, including financial covenants requiring a minimum debt service coverage ratio of 1.75 to 1.00, tested on a rolling four-quarter basis, and a maximum debt to capitalization ratio (funded debt divided by the sum of total net worth and funded debt) of 0.75 to 1, tested quarterly. At September 30, 2012, we were in compliance with these covenants. Our obligations under the Credit Agreement are secured by our accounts receivable and inventory, as well as real property and equipment at Kinpak’s Montgomery, Alabama facility.

See notes 6 and 7 to the condensed consolidated financial statements included in this report for additional information.

In addition to the revolving line of credit and term loan, we have obtained financing through capital leases for both manufacturing and office equipment, totaling approximately $42,200 and $62,400 at September 30, 2012 and December 31, 2011, respectively.

We sell our products in the Canadian market and are subject to currency fluctuations relating to the Canadian dollar.  We do not engage in currency hedging and address currency risk as a pricing issue.  In the nine months ended September 30, 2012, we recorded $6,356 in foreign currency translation adjustments (increasing shareholders’ equity by $6,356) as a result of the strengthening of the Canadian dollar in relation to the US dollar.

During the past few years, we have introduced a number of new products to our customers.  At times, new product introductions have required us to increase our overall inventory and have resulted in lower inventory turnover rates.  The effects of reduced inventory turnover have not been material to our overall operations.  We believe that we can continue to provide, through our operations and financing arrangements, all required capital to support increased inventory levels.

Many of the raw materials that we use in the manufacturing process are petroleum-based or chemical-based and are subject to fluctuating prices.  The nature of our business does not enable us to pass through the price increases to our national retailers and distributors as promptly as we experience increases in raw material costs.  This may, at times, adversely affect our margins.

At September 30, 2012 and through the date of this report, we did not and do not have any material commitments for capital expenditures or inventories, nor do we have any other present commitment that is likely to result in our liquidity increasing or decreasing in any material way.

We believe that funds provided through operations and its existing sources of financing will be sufficient to satisfy our cash requirements over at least the next twelve months.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Not applicable

16

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures:

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act") at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures as of the end of the period covered by this report are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act are (i) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.

Change in Internal Controls over Financial Reporting:

No change in internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1A. – Risk Factors

In addition to the information set forth in this report, you should carefully consider the factors discussed in Item 1A, "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2011, which could materially affect the Company’s business, financial condition or future results.

Item 6. – Exhibits

Exhibit No.	Description
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act. *
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act. *
32.1	Certification of Chief Executive Officer pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350. *
32.2	Certification of Chief Financial Officer pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350. *
101	The following materials from Ocean Bio-Chem, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2012, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of September 30, 2012 and December 31, 2011, (ii) Condensed Consolidated Statements of Operations for the three months  and nine months ended September, 2012 and 2011, (iii) Condensed Consolidated Statements of Comprehensive Income for the three months and nine months ended September 30, 2012 and 2011; (iv) Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2012 and 2011 and (v) Notes  to Condensed Consolidated Financial Statements. .

_______________

* Filed herewith.

17

SIGNATURES

             Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on behalf by the Undersigned thereuntoduly authorized.

	OCEAN BIO-CHEM, INC.
Dated:           November 14, 2012	/s/ Peter G. Dornau
	Peter G. Dornau
	Chairman of the Board, President and
	Chief Executive Officer
	(Principal Executive Officer)
Dated:           November 14, 2012	/s/ Jeffrey S. Barocas
	Jeffrey S. Barocas
	Vice President and
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

18

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Peter G. Dornau certify that:

1.  I have reviewed this Quarterly Report on Form 10-Q of Ocean Bio-Chem, Inc.;

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.  The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:  November 14, 2012	/s/ Peter G. Dornau
	Peter G. Dornau
	Chairman of the Board, President and
	Chief Executive Officer
	(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Jeffrey S. Barocas certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Ocean Bio-Chem, Inc;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:  November 14, 2012	By:	/s/ Jeffrey S. Barocas
		Jeffrey S. Barocas
		Vice President
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO RULE 13a-14(b)

UNDER THE SECURITIES EXCHANGE ACT AND 18 U.S.C. 1350

I, Peter G. Dornau, Chief Executive Officer of Ocean Bio-Chem, Inc. (the "Company"), hereby certify that, based on my knowledge:

1. The Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2012 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:  November 14, 2012	By:	/s/ Peter G. Dornau
		Peter G. Dornau
		Chairman of the Board, President and
		Chief Executive Officer (Principal Executive Officer)

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO RULE 13a-14(b)

UNDER THE SECURITIES EXCHANGE ACT AND 18 U.S.C. 1350

I, Jeffrey S. Barocas, Chief Financial Officer of Ocean Bio-Chem, Inc. (the "Company"), hereby certify that, based on my knowledge:

1. The Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2012 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:  November 14, 2012	By:	/s/ Jeffrey S. Barocas
		Jeffrey S. Barocas
		Vice President
		Chief Financial Officer (Principal Financial and Accounting Officer)

XML

Commitments (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	May 01, 2008
Fort Lauderdale Florida Facility [Member]
Commitments (Textual)
Renewal of lease term					10 years
Minimum base rent			$ 94,800
Maximum percentage increase in base rent			2.00%
Period to review term of lease			3 years
Rent and additional expenses (Annually)	24,000	24,000	73,000	73,000
Alabama River Facility [Member]
Commitments (Textual)
Leased area for docking facility (in Acres)			1.5
Lease expiration date			Sep. 30, 2014
Distance of docking facility from company (in Miles)			11
Rent and additional expenses (Annually)			$ 7,800

XML

Inventories (Details Textual) (USD $)	Sep. 30, 2012	Dec. 31, 2011
Inventories (Textual)
Inventories managed at the customer’s warehouses	$ 548,000	$ 570,000

XML

Inventories

9 Months Ended

Sep. 30, 2012

Inventories [Abstract]

INVENTORIES

3. INVENTORIES

The composition of inventories at September 30, 2012 and December 31, 2011 are as follows:

	September 30, 2012			December 31, 2011
Raw materials	$	4,448,470		$	4,431,651
Finished goods		5,372,553			5,472,850
Inventories, gross		9,821,023			9,904,501
Inventory reserves		(285,738	)		(276,703	)
Inventories, net	$	9,535,285		$	9,627,798

The inventory reserves shown in the table above reflect slow moving and obsolete inventory.

The Company operates a vendor managed inventory program with one of its customers to improve the promotion of the Company's products.  The Company manages the inventory levels at this customer’s warehouses and recognizes revenue as the products are sold by the customer.  The inventories managed at the customer’s warehouses amounted to approximately $548,000 and $570,000 at September 30, 2012 and December 31, 2011, respectively.

XML

Long Term Debt (Details) (USD $)	Sep. 30, 2012	Dec. 31, 2011
Component of long term debt
Total long term debt, Current Portion	$ 404,271	$ 400,430
Total long term debt, Long Term Portion	1,634,906	1,939,362
Term loan [Member]
Component of long term debt
Total long term debt, Current Portion	385,652	375,562
Total long term debt, Long Term Portion	1,611,316	1,901,830
Capitalized equipment leases [Member]
Component of long term debt
Total long term debt, Current Portion	18,619	24,868
Total long term debt, Long Term Portion	$ 23,590	$ 37,532

XML

Revolving Line of Credit (Details) (USD $)	9 Months Ended
	Sep. 30, 2012	Dec. 31, 2011
Revolving Line Of Credit (Textual)
Term of revolving line of credit	The Company may borrow up to the lesser of (i) $6 million or (ii) a borrowing base equal to 80% of eligible accounts receivable plus 50% of eligible inventory.
Maximum borrowing capacity of the company	$ 6,000,000
Percentage of eligible accounts receivables as part of borrowing base	80.00%
Percentage of eligible inventory as part of the borrowing base	50.00%
Interest on the revolving line of credit	30 day LIBOR rate plus 1.74% per annum.
Minimum debt service coverage ratio to qualify for LIBOR plus 1.74%	2.0
Alternate interest rate condition if it doesn't satisfy the debt coverage ratio	30 day LIBOR rate plus 2.75% per annum.
Interest rate minimum	2.00%
Financial covenants under credit agreement	A minimum debt service coverage ratio of 1.75 to 1.00, tested on a rolling four-quarter basis, and a maximum debt to capitalization ratio (funded debt divided by the sum of total net worth and funded debt) of 0.75 to 1, tested quarterly.
Due date of outstanding principal and interest borrowed under revolving line of credit	Jul. 06, 2014
Debt capitalization ratio	0.75
Company’s principal obligation under the revolving line of credit	$ 1,700,000	$ 850,000
Interest rate	2.00%	2.00%

XML

Long Term Debt (Details 1) (USD $)	Sep. 30, 2012
Company’s long term obligations for 12 month period ending September 30
2013	$ 404,271
2014	412,786
2015	423,384
2016	429,645
2017	369,091
Total	$ 2,039,177

XML

Long Term Debt (Details Textual) (USD $)	9 Months Ended
	Sep. 30, 2012	Dec. 31, 2011	Jul. 06, 2011 REFCO [Member]
Long Term Debt (Textual)
Term loan	$ 1,997,000		$ 2,430,000
Interest rate			3.54%
Term loan maturity date	Jul. 06, 2017
Aggregate capital lease	$ 42,209	$ 62,400
Maturity period for capital lease	Through 2015
Interest rates minimum	7.00%
Interest rates maximum	14.00%

XML

Recent Accounting Pronouncements

9 Months Ended

Sep. 30, 2012

Recent Accounting Pronouncements [Abstract]

RECENT ACCOUNTING PRONOUNCEMENTS

2. RECENT ACCOUNTING PRONOUNCEMENTS

There have been no accounting pronouncements or changes in accounting pronouncements during the nine months ended September 30, 2012 that are expected to have a material impact on the Company’s financial position, results of operations or cash flows.  Accounting pronouncements that became effective during the nine months ended September 30, 2012 did not have a material impact on disclosures or on the Company’s financial position, results of operations or cash flows.

XML

Related Party Transactions (Details) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2010	Dec. 31, 2011	Dec. 06, 2010
Related Party Transactions (Textual)
Sales to the affiliated companies	$ 386,000	$ 325,000	$ 997,000	$ 1,159,000
Administrative fees	70,000	78,000	216,000	178,000
Accounts receivable from the affiliated companies	335,746		335,746			495,130
Amount paid to entity for services	10,500	10,500	31,500	31,500
Warrants redeemed							500,000
Exercise price of warrant					$ 0.836
Aggregate redemption price of the warrant					471,950
Note interest rate			3.00%
Insurance premiums paid	$ 171,000	$ 304,000	$ 443,000	$ 28,000

XML

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2012	Dec. 31, 2011
Current Assets:
Cash	$ 775,399	$ 585,357
Trade accounts receivable net of allowance for doubtful accounts of approximately $135,000 and $75,000 at September 30, 2012 and December 31, 2011, respectively	5,912,093	2,563,089
Receivables due from affiliated companies	335,746	495,130
Inventories, net	9,535,285	9,627,798
Prepaid expenses and other current assets	536,621	424,168
Deferred tax asset	134,030	65,797
Total Current Assets	17,229,174	13,761,339
Property, plant and equipment, net	5,100,690	5,213,333
Other Assets:
Trademarks, trade names and patents, net	832,056	870,642
Other assets	25,591	33,442
Total Other Assets	857,647	904,084
Total Assets	23,187,511	19,878,756
Current Liabilities:
Accounts payable – trade	2,274,721	1,162,143
Revolving line of credit	1,700,000	850,000
Current portion of long term debt	404,271	400,430
Income taxes payable	33,381	353,608
Accrued expenses payable	980,370	889,444
Total Current Liabilities	5,392,743	3,655,625
Deferred tax liability	296,351	250,191
Long term debt, less current portion	1,634,906	1,939,362
Total Liabilities	7,324,000	5,845,178
Commitments and contingencies
Shareholders' Equity:
Common stock - $.01 par value, 12,000,000 shares authorized; 8,640,116 and 8,458,389 shares issued at September 30, 2012 and December 31, 2011, respectively	86,401	84,584
Additional paid in capital	8,516,870	8,163,864
Less cost of common stock in treasury, 351,503 shares at September 30, 2012 and December 31, 2011, respectively	(288,013)	(288,013)
Foreign currency translation adjustment	(261,728)	(268,084)
Retained earnings	7,556,770	6,058,848
Total Shareholders' Equity of Ocean Bio-Chem, Inc.	15,610,300	13,751,199
Noncontrolling interest	253,211	282,379
Total Shareholders' Equity	15,863,511	14,033,578
Total Liabilities and Shareholders' Equity	$ 23,187,511	$ 19,878,756

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Cash flows from operating activities:
Net income	$ 1,468,754	$ 2,132,665
Adjustments to reconcile net income to net cash used in operating activities
Depreciation and amortization	522,499	584,625
Deferred income taxes	(22,073)	160,482
Stock based compensation	267,477	388,866
Other operating non-cash items	87,654	122,462
Changes in assets and liabilities:
Trade accounts receivable	(3,409,339)	(3,291,494)
Inventories	83,478	(2,967,069)
Other assets	7,851	10,943
Prepaid expenses and other current assets	(112,453)	(182,728)
Receivables due from affiliated companies	159,384	23,312
Accounts payable and other accrued expenses	883,277	1,114,769
Net cash used in operating activities	(63,491)	(1,903,167)
Cash flows from investing activities:
Purchases of property, plant and equipment	(374,428)	(313,276)
Contributions from joint venture		36,842
Net cash used in investing activities	(374,428)	(276,434)
Cash flows from financing activities:
Net borrowings under revolving line of credit	850,000	3,400,000
Proceeds from issuance of long term debt		2,430,000
Repayments of notes payable related party		(471,950)
Payments on long-term debt	(300,615)	(2,988,581)
Proceeds from exercise of stock options	78,020	6,300
Net cash provided by financing activities	627,405	2,375,769
Effect of exchange rates on cash	556	(1,950)
Net increase in cash	190,042	194,218
Cash at beginning of period	585,357	615,044
Cash at end of period	775,399	809,262
Supplemental disclosure of cash transactions:
Cash paid for interest during period	76,203	118,594
Cash paid for income taxes during period	$ 1,212,879	$ 1,259,000

XML

Securities Authorized for Issuance Under Equity Compensation Plans (Details) (USD $)	9 Months Ended
	Sep. 30, 2012
Outstanding options under the Company’s stock option plans
Options Outstanding	656,400
Exercisable Options	590,580
Exercise Price	$ 1.07
Weighted Average Remaining Life	2 years
Non Plan [Member]
Outstanding options under the Company’s stock option plans
Date Granted	Mar. 25, 2009
Options Outstanding	115,000
Exercisable Options	115,000
Exercise Price	$ 0.55
Expiration Date	Mar. 24, 2014
Weighted Average Remaining Life	1 year 6 months
2007 ISO [Member]
Outstanding options under the Company’s stock option plans
Date Granted	Oct. 08, 2007
Options Outstanding	2,500
Exercisable Options	2,000
Exercise Price	$ 1.87
Expiration Date	Oct. 07, 2012
Weighted Average Remaining Life	0 years
2007 ISO 1 [Member]
Outstanding options under the Company’s stock option plans
Date Granted	Dec. 17, 2007
Options Outstanding	141,000
Exercisable Options	109,700
Exercise Price	$ 1.32
Expiration Date	Dec. 16, 2012
Weighted Average Remaining Life	2 months 12 days
2008 ISO [Member]
Outstanding options under the Company’s stock option plans
Date Granted	Aug. 25, 2008
Options Outstanding	142,900
Exercisable Options	108,880
Exercise Price	$ 0.97
Expiration Date	Aug. 24, 2013
Weighted Average Remaining Life	10 months 24 days
2002NQ [Member]
Outstanding options under the Company’s stock option plans
Date Granted	Oct. 22, 2002
Options Outstanding	30,000
Exercisable Options	30,000
Exercise Price	$ 1.26
Expiration Date	Oct. 21, 2012
Weighted Average Remaining Life	1 month 6 days
2002NQ 1 [Member]
Outstanding options under the Company’s stock option plans
Date Granted	Jun. 20, 2003
Options Outstanding	30,000
Exercisable Options	30,000
Exercise Price	$ 1.03
Expiration Date	Jun. 19, 2013
Weighted Average Remaining Life	8 months 12 days
2002NQ 2 [Member]
Outstanding options under the Company’s stock option plans
Date Granted	May 25, 2004
Options Outstanding	30,000
Exercisable Options	30,000
Exercise Price	$ 1.46
Expiration Date	May 24, 2014
Weighted Average Remaining Life	1 year 8 months 12 days
2002NQ 3 [Member]
Outstanding options under the Company’s stock option plans
Date Granted	Apr. 03, 2006
Options Outstanding	40,000
Exercisable Options	40,000
Exercise Price	$ 1.08
Expiration Date	Apr. 02, 2016
Weighted Average Remaining Life	3 years 7 months 6 days
2002NQ 4 [Member]
Outstanding options under the Company’s stock option plans
Date Granted	Dec. 17, 2007
Options Outstanding	50,000
Exercisable Options	50,000
Exercise Price	$ 1.32
Expiration Date	Dec. 16, 2017
Weighted Average Remaining Life	5 years 3 months 18 days
2008NQ [Member]
Outstanding options under the Company’s stock option plans
Date Granted	Jan. 11, 2009
Options Outstanding	50,000
Exercisable Options	50,000
Exercise Price	$ 0.69
Expiration Date	Jan. 10, 2019
Weighted Average Remaining Life	6 years 4 months 24 days
2008NQ 1 [Member]
Outstanding options under the Company’s stock option plans
Date Granted	Apr. 26, 2010
Options Outstanding	25,000
Exercisable Options	25,000
Exercise Price	$ 2.07
Expiration Date	Apr. 25, 2020
Weighted Average Remaining Life	7 years 8 months 12 days

XML

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2012

Earnings Per Share [Abstract]

Computation of basic and diluted earnings per common share

	Three Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012		2011
Earnings per common share -Basic
Net income attributable to OBCI	$	770,618	$	1,137,685	$	1,497,922	$	2,175,382
Weighted average number of common shares outstanding		8,288,613		7,997,613		8,201,376		7,916,932
Earnings per common share - Basic	$	0.09	$	0.14	$	0.18	$	0.27
Earnings per common share – Diluted
Net income attributable to OBCI	$	770,618	$	1,137,685	$	1,497,922	$	2,175,382
Weighted average number of common shares outstanding		8,288,613		7,997,613		8,201,376		7,916,932
Effect of employee stock-based awards		306,893		540,193		339,401		477,481
Weighted average number of common shares outstanding - assuming dilution		8,595,506		8,537,806		8,540,777		8,394,413
Earnings per common share - Diluted	$	0.09	$	0.13	$	0.18	$	0.26

XML

Securities Authorized for Issuance Under Equity Compensation Plans (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Securities Authorized For Issuance Under Equity Compensation Plans (Textual)
Shares issued under stock plan			64,727
Securities Authorized For Issuance Under Equity Compensation Plans (Additional Textual)
Non cash stock compensation expense attributable to stock options	$ 10,000	$ 23,000	$ 44,000	$ 68,000
Unrecognized compensation expense related to options awarded to employees	22,000		22,000
Stock option excercised			132,800
Stock option expired			6,500
Surrender of shares in connection with excercise of stock option			68,073
Stock based compensation attributable to stock award	$ 0	$ 0	$ 223,000	$ 321,000
2011 Omnibus Equity Compensation Plan [Member]
Securities Authorized For Issuance Under Equity Compensation Plans (Textual)
Shares issued under stock plan			117,000

XML

Inventories (Details) (USD $)	Sep. 30, 2012	Dec. 31, 2011
Composition of inventories
Raw materials	$ 4,448,470	$ 4,431,651
Finished goods	5,372,553	5,472,850
Inventories, gross	9,821,023	9,904,501
Inventory reserves	(285,738)	(276,703)
Inventories, net	$ 9,535,285	$ 9,627,798

XML

Summary of Accounting Policies

9 Months Ended

Sep. 30, 2012

Summary Of Accounting Policies [Abstract]

SUMMARY OF ACCOUNTING POLICIES

1. SUMMARY OF ACCOUNTING POLICIES

Interim reporting

The accompanying unaudited condensed consolidated financial statements include the accounts of Ocean Bio-Chem, Inc. and its subsidiaries, all of which are wholly-owned, and OdorStar Technology LLC (“OdorStar”), a joint venture in which the Company has a controlling interest.  All significant intercompany transactions and balances have been eliminated in consolidation.  Certain prior-period data have been reclassified to conform to the current period presentation.  Unless the context indicates otherwise, the term “Company” refers to Ocean Bio-Chem, Inc. and its subsidiaries

The unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.

The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods.  The results of operations for the three and nine months ended September 30, 2012 are not necessarily indicative of the results to be expected for the year ending December 31, 2012.

The information included in this Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2011.

Use of estimates

The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates and assumptions.

Subsequent events

The Company evaluates events through the date the financial statements are filed to determine whether such events require adjustment to or disclosure in the financial statements.

XML

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2012	Dec. 31, 2011
Condensed Consolidated Balance Sheets [Abstract]
Trade accounts receivable, allowance for doubtful accounts	$ 135,000	$ 75,000
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	12,000,000	12,000,000
Common stock, shares issued	8,640,116	8,458,389
Common stock in treasury, shares	351,503	351,503

XML

Securities Authorized for Issuance Under Equity Compensation Plans

9 Months Ended

Sep. 30, 2012

Securities Authorized For Issuance Under Equity Compensation Plans [Abstract]

SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

11.  SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

On May 9, 2012, the Company issued stock awards covering 117,000 shares of common stock under its 2011 Omnibus Equity Compensation Plan. The Company recognized compensation expense based upon the average of the high and low trading price of its common stock on the issuance date.

On May 17, 2012, stock options with respect to 132,800 shares were exercised, and options related to 6,500 shares expired. Following the surrender of 68,073 shares in connection with a net exercise feature of the stock options, the Company issued an aggregate of 64,727 shares.

There was no stock compensation expense related to stockawards during the three months ended September 30, 2012 and 2011.  Non cash stock based compensation recognized during the nine months ended September 30, 2012 and 2011 attributable to stock awards totaled approximately $223,000 and $321,000, respectively.  Non cash stock compensation expense attributable to stock options was approximately $10,000 and $23,000 for the three months ended September 30, 2012 and 2011, respectively.  Non cash stock compensation expense attributable to stock options was approximately $44,000 and $68,000 for the nine months ended September 30, 2012 and 2011, respectively.

At September 30, 2012, there was approximately $22,000 of unrecognized compensation expense related to stockoptions awarded to employees.  This cost will be charged as compensation expense through 2013, as the stock options vest.

The following table provides information at September 30, 2012 regarding outstandingstock options under the Company’s stock option plans as well as a grant made outside of the Company’s stock option plans. As used in the table below, “2007 ISO” refers to the Company’s 2007 Incentive Stock Option Plan, “2008 ISO” refers to the Company’s 2008 Incentive Stock Option Plan, “2002 NQ” refers to the Company’s 2002 Non-Qualified Stock Option Plan and “2008 NQ” refers to the Company’s 2008 Non-Qualified Stock Option Plan.

Plan	Date Granted	Options Outstanding		Exercisable Options	Exercise Price		Expiration Date	Weighted Average Remaining Life
Non Plan	3/25/09		115,000	115,000	$	0.55	3/24/14	1.5
2007 ISO	10/08/07		2,500	2,000		1.87	10/07/12	0.0
2007 ISO	12/17/07		141,000	109,700		1.32	12/16/12	0.2
2008 ISO	8/25/08		142,900	108,880		0.97	8/24/13	0.9
2002NQ	10/22/02		30,000	30,000		1.26	10/21/12	0.1
2002NQ	6/20/03		30,000	30,000		1.03	6/19/13	0.7
2002NQ	5/25/04		30,000	30,000		1.46	5/24/14	1.7
2002NQ	4/03/06		40,000	40,000		1.08	4/02/16	3.6
2002NQ	12/17/07		50,000	50,000		1.32	12/16/17	5.3
2008NQ	1/11/09		50,000	50,000		0.69	1/10/19	6.4
2008NQ	4/26/10		25,000	25,000		2.07	4/25/20	7.7
			656,400	590,580	$	1.07		2.0

XML

Document and Entity Information	9 Months Ended
	Sep. 30, 2012	Nov. 14, 2012
Document and Entity Information [Abstract]
Entity Registrant Name	OCEAN BIO CHEM INC
Entity Central Index Key	0000350737
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Sep. 30, 2012
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q3
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		8,299,763

XML

Summary of Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2012

Summary Of Accounting Policies [Abstract]

Interim reporting

Interim reporting

The accompanying unaudited condensed consolidated financial statements include the accounts of Ocean Bio-Chem, Inc. and its subsidiaries, all of which are wholly-owned, and OdorStar Technology LLC (“OdorStar”), a joint venture in which the Company has a controlling interest.  All significant intercompany transactions and balances have been eliminated in consolidation.  Certain prior-period data have been reclassified to conform to the current period presentation.  Unless the context indicates otherwise, the term “Company” refers to Ocean Bio-Chem, Inc. and its subsidiaries

The unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.

The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods.  The results of operations for the three and nine months ended September 30, 2012 are not necessarily indicative of the results to be expected for the year ending December 31, 2012.

The information included in this Form 10-Q should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2011.

Use of estimates

Use of estimates

The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates and assumptions.

Subsequent events

Subsequent events

The Company evaluates events through the date the financial statements are filed to determine whether such events require adjustment to or disclosure in the financial statements.

XML

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Condensed Consolidated Statement Of Operation [Abstract]
Gross sales	$ 10,750,275	$ 10,429,694	$ 25,446,178	$ 26,184,476
Less: discounts, returns, and allowances	488,413	545,643	1,297,936	1,349,944
Net sales	10,261,862	9,884,051	24,148,242	24,834,532
Cost of goods sold	6,997,495	6,538,236	15,877,264	16,002,122
Gross profit	3,264,367	3,345,815	8,270,978	8,832,410
Operating Expenses:
Advertising and promotion	783,523	476,366	1,890,438	1,506,145
Selling and administrative	1,305,613	1,241,053	3,964,994	4,017,667
Total operating expenses	2,089,136	1,717,419	5,855,432	5,523,812
Operating income	1,175,231	1,628,396	2,415,546	3,308,598
Other income (expense)
Interest expense	(22,138)	(34,835)	(75,586)	(108,054)
Other (expense) income	(3,449)	13,227	(627)	38,738
Income before income taxes	1,149,644	1,606,788	2,339,333	3,239,282
Provision for income taxes	388,755	478,649	870,579	1,106,617
Net income	760,889	1,128,139	1,468,754	2,132,665
Loss attributable to noncontrolling interests	9,729	9,546	29,168	42,717
Net income attributable to Ocean Bio-Chem, Inc.	$ 770,618	$ 1,137,685	$ 1,497,922	$ 2,175,382
Earnings per common share – basic	$ 0.09	$ 0.14	$ 0.18	$ 0.27
Earnings per common share – diluted	$ 0.09	$ 0.13	$ 0.18	$ 0.26
Weighted average shares - basic	8,288,613	7,997,613	8,201,376	7,916,932
Weighted average shares - diluted	8,595,506	8,537,806	8,540,777	8,394,413

XML

Revolving Line of Credit

9 Months Ended

Sep. 30, 2012

Revolving Line Of Credit and Long Term Debt [Abstract]

REVOLVING LINE OF CREDIT

6. REVOLVING LINE OF CREDIT

On July 6, 2011, the Company, together with its subsidiary, Kinpak Inc. (“Kinpak”), entered into a Credit Agreement with Regions Bank (and, pursuant to an Equipment Finance Addendum to the Credit Agreement, Regions Equipment Finance Corporation (“REFCO”)).  Under the Credit Agreement, the Company’s revolving line of credit with Regions Bank was renewed.  The terms of the revolving line of credit, as renewed, provide that the Company may borrow up to the lesser of (i) $6 million or (ii) a borrowing base equal to 80% of eligible accounts receivable plus 50% of eligible inventory.  Interest on the revolving line of credit is payable at the 30 day LIBOR rate plus 1.74% per annum (unless the Company’s debt service coverage ratio (net profit plus taxes, interest, depreciation, amortization and rent expense divided by debt service plus interest and lease/rent expense) falls below 2.0 to 1, in which case the interest is payable at the 30 day LIBOR rate plus 2.75% per annum).  In no event will the interest rate be less than 2.0% per annum.  Outstanding amounts under the revolving line of credit are payable on demand.  If no demand is made, the Company may repay and reborrow funds from time to time.  The Company’s obligations under the revolving line of credit are secured by the Company’s accounts receivable and inventory, as well as real property and equipment at Kinpak’s Montgomery, Alabama facility. The Company’s obligations under the revolving line of credit and the term loan discussed in footnote 7 below are cross-collateralized.  Interest on amounts borrowed under the revolving line of credit is payable in monthly installments on outstanding average balances, with all outstanding principal and interest payable on July 6, 2014.  The Credit Agreement includes financial covenants requiring a minimum debt service coverage ratio of 1.75 to 1.00, tested on a rolling four-quarter basis, and a maximum debt to capitalization ratio (funded debt divided by the sum of total net worth and funded debt) of 0.75 to 1, tested quarterly.  At September 30, 2012, the Company was in compliance with these covenants. The Company’s principal obligations under the revolving line of credit were $1,700,000 and $850,000 at September 30, 2012 and December 31, 2011, respectively.  The interest rate was 2.0% per annum at September 30, 2012 and December 31, 2011.

XML

Noncontrolling Interest

9 Months Ended

Sep. 30, 2012

Noncontrolling Interest [Abstract]

NONCONTROLLING INTEREST

5. NONCONTROLLING INTEREST

On May 10, 2010, the Company and BBL Distributors, LLC formed OdorStar. OdorStar owns patents that relate to a formula and delivery system, for use with products containing chlorine dioxide, designed to safely prevent and eliminate odors relating to mold, mildew and other sources of unpleasant odors.  The Company and BBL Distributors, LLC share equally in profits or losses from OdorStar.  Because the Company manages OdorStar, it has consolidated OdorStar in its financial statements.  The Company’s condensed consolidated financial statements include approximately $507,000 and $541,000 in assets and $7,000 and $6,000 in liabilities from OdorStar at September 30, 2012 and December 31, 2011, respectively.  The Company’s condensed consolidated financial statements also include OdorStar’s operating losses of approximately $19,000 and $19,000during the three months ended September 30, 2012 and 2011, respectively, and $58,000 and $85,000during the nine months ended September 30, 2012 and 2011, respectively.

XML

Securities Authorized for Issuance Under Equity Compensation Plans (Tables)

9 Months Ended

Sep. 30, 2012

Securities Authorized For Issuance Under Equity Compensation Plans [Abstract]

Schedule of outstanding stock options under Company’s stock option plans

Plan	Date Granted	Options Outstanding		Exercisable Options	Exercise Price		Expiration Date	Weighted Average Remaining Life
Non Plan	3/25/09		115,000	115,000	$	0.55	3/24/14	1.5
2007 ISO	10/08/07		2,500	2,000		1.87	10/07/12	0.0
2007 ISO	12/17/07		141,000	109,700		1.32	12/16/12	0.2
2008 ISO	8/25/08		142,900	108,880		0.97	8/24/13	0.9
2002NQ	10/22/02		30,000	30,000		1.26	10/21/12	0.1
2002NQ	6/20/03		30,000	30,000		1.03	6/19/13	0.7
2002NQ	5/25/04		30,000	30,000		1.46	5/24/14	1.7
2002NQ	4/03/06		40,000	40,000		1.08	4/02/16	3.6
2002NQ	12/17/07		50,000	50,000		1.32	12/16/17	5.3
2008NQ	1/11/09		50,000	50,000		0.69	1/10/19	6.4
2008NQ	4/26/10		25,000	25,000		2.07	4/25/20	7.7
			656,400	590,580	$	1.07		2.0

XML

Inventories (Tables)

9 Months Ended

Sep. 30, 2012

Inventories [Abstract]

Composition of inventories

	September 30, 2012			December 31, 2011
Raw materials	$	4,448,470		$	4,431,651
Finished goods		5,372,553			5,472,850
Inventories, gross		9,821,023			9,904,501
Inventory reserves		(285,738	)		(276,703	)
Inventories, net	$	9,535,285		$	9,627,798

XML

Commitments

9 Months Ended

Sep. 30, 2012

Commitments [Abstract]

COMMITMENTS

9. COMMITMENTS

The Company leases its executive offices and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer. On May 1, 2008, the Company renewed the lease for a term of ten years. The lease requires annual minimum base rent of $94,800 and provides for a maximum annual 2% increase in subsequent years, although the entity has not raised the minimum rent since the Company entered into the initial lease agreement in 1998. Additionally, the leasing entity is entitled to reimbursement of all taxes, assessments, and any other expenses that arise from ownership. Each of the parties to the lease has agreed to review the terms of the lease every three years at the request of the other party.  Rent expense under the lease was approximately $24,000 for each of the three month periods ended September 30, 2012 and 2011, and was approximately $73,000 for each ofthe nine month periods ended September 30, 2012 and 2011.

The Company leases from the Alabama State Port Authority a 1.5 acre docking facility on the Alabama River, located approximately eleven miles from the Company’s Alabama manufacturing facility.  The lease expires on September 30, 2014, and requires the Company to pay rent and additional expenses totaling approximately $7,800 annually.

XML

Long Term Debt

9 Months Ended

Sep. 30, 2012

Revolving Line Of Credit and Long Term Debt [Abstract]

LONG TERM DEBT

7. LONG TERM DEBT

On July 6, 2011, under the Equipment Finance Addendum to the Credit Agreement, REFCO provided to the Company a $2,430,000 term loan with a fixed interest rate of 3.54%.  Principal and interest on the term loan are payable in equal monthly installments through July 6, 2017, the date on which the term loan matures.  The proceeds of the term loan were used to pay the Company’s remaining obligations under a lease agreement relating to industrial revenue bonds used to fund the expansion of Kinpak’s facilities and acquisition of related equipment.  At September 30, 2012, approximately $1,997,000 was outstanding under the term loan.

At September 30, 2012 and December 31, 2011, the Company was obligated under various capital lease agreements covering equipment utilized in the Company’s operations.  The capital leases, aggregating $42,209 and $62,400 at September 30, 2012 and December 31, 2011, respectively, have varying maturities through 2015 and carry interest rates ranging from 7% to 14%.

The following table provides information regarding the Company’s long term debt at September 30, 2012 and December 31, 2011:

	Current Portion				Long Term Portion
	September 30,  2012		December 31, 2011		September 30,  2012		December 31, 2011
Term loan		385,652		375,562		1,611,316		1,901,830
Capitalized equipment leases		18,619		24,868		23,590		37,532
Total long term debt	$	404,271	$	400,430	$	1,634,906	$	1,939,362

Required principal payments under the Company’s long term obligations are set forth below:

12 month period ending September 30,
2013	$	404,271
2014		412,786
2015		423,384
2016		429,645
2017		369,091
Total	$	2,039,177

XML

Related Party Transactions

9 Months Ended

Sep. 30, 2012

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS

8. RELATED PARTY TRANSACTIONS

During the three and nine months ended September 30, 2012 and 2011, the Company sold products to companies affiliated with its Chairman, President and Chief Executive Officer. The affiliated companies distribute the products outside of the United States and Canada. The Company also provides administrative services to these companies. Sales to the affiliated companies aggregated approximately $386,000 and $325,000during the three months ended September 30, 2012 and 2011, respectively, and $997,000 and $1,159,000for the nine months ended September 30, 2012 and 2011, respectively.  Administrative fees aggregated approximately $70,000 and $78,000during the three months ended September 30, 2012 and 2011, respectively, and $216,000 and $178,000for the nine months ended September 30, 2012 and 2011, respectively.  The Company had accounts receivable from the affiliated companies in connection with the product sales and administrative services aggregating approximately $336,000 and $495,000 at September 30, 2012 and December 31, 2011, respectively. Transactions with the affiliated companies were made in the ordinary course of business.   While the terms of sale to the affiliated companies differ from other customers, the affiliated companies bear their own warehousing, distribution, advertising, selling and marketing costs, as well as their own freight charges (the company pays freight charges in connection with sales to its domestic customers on all but small orders).  Moreover, the Company does not pay sales commissions with respect to products sold to the affiliated companies.  As a result, the Company believes its profit margins with respect to sales to the affiliated companies are similar to the profit margins with respect to sales to its larger domestic customers. 

A subsidiary of the Company currently uses the services of an entity that is owned by the Chairman, President and Chief Executive Officer of the Company to conduct product research and development, marketing and advertising.  The Company paid the entity approximately $10,500 for each of the three month periods ended September 30, 2012 and 2011, and $31,500 for each of the nine month periods ended September 30, 2012 and 2011, under this arrangement.

The Company leases office and warehouse facilities in Fort Lauderdale, Florida from an entity controlled by its Chairman, President and Chief Executive Officer.  The Company believes that the rental payments are below market rates.  See Note 9 for a description of the lease terms.

On December 6, 2010, the Company redeemed a warrant held by its Chairman, President and Chief Executive Officer to purchase 500,000 shares of its Common Stock at an exercise price of $0.836 per share.  The warrant initially was issued to him in connection with financing he provided to the Company in December 2005.  The aggregate redemption price of the warrant was $471,950, which was based on the difference between the closing price of the Company's Common Stock on December 6, 2010 and the exercise price of the warrant.  The Company issued a note to the Chairman, President and Chief Executive Officer in an amount equal to the redemption price, which bore interest at the rate of 3% per annum.  On January 5, 2011, the Company paid all outstanding principal and interest on the note.  The redemption, which was approved by the independent directors of the Board of Directors, was effected in order to prevent the dilutive effect of the exercise of the warrant.

A director of the Company is Regional Executive Vice President of an entity from which the Company sources most of its insurance needs at an arm’s length competitive basis.  During the three months ended September 30, 2012 and 2011, the Company paid an aggregate of approximately $171,000 and $304,000, respectively, and during the nine months ended September 30, 2012 and 2011, the Company paid an aggregate of approximately $443,000 and $528,000 respectively, in insurance premiums on policies obtained through the entity.

XML

Earnings Per Share

9 Months Ended

Sep. 30, 2012

Earnings Per Share [Abstract]

EARNINGS PER SHARE

10. EARNINGS PER SHARE

Basic earnings per share is calculated based on net income attributable to Ocean Bio-Chem, Inc. and the weighted average number of shares outstanding during the reported period.  Diluted earnings per share reflect additional dilution from potential common stock issuable upon the exercise of outstanding stock options.  The following table sets forth the computation of basic and diluted earnings per common share, as well as a reconciliation of the weighted average number of common shares outstanding to the weighted average number of shares outstanding on a diluted basis.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012		2011
Earnings per common share -Basic
Net income attributable to OBCI	$	770,618	$	1,137,685	$	1,497,922	$	2,175,382
Weighted average number of common shares outstanding		8,288,613		7,997,613		8,201,376		7,916,932
Earnings per common share - Basic	$	0.09	$	0.14	$	0.18	$	0.27
Earnings per common share – Diluted
Net income attributable to OBCI	$	770,618	$	1,137,685	$	1,497,922	$	2,175,382
Weighted average number of common shares outstanding		8,288,613		7,997,613		8,201,376		7,916,932
Effect of employee stock-based awards		306,893		540,193		339,401		477,481
Weighted average number of common shares outstanding - assuming dilution		8,595,506		8,537,806		8,540,777		8,394,413
Earnings per common share - Diluted	$	0.09	$	0.13	$	0.18	$	0.26

The Company had no stock options outstanding for the three and nine months ended September 30, 2012 and 2011, respectively, that were anti-dilutive and therefore not included in the diluted earnings per common share calculation.

XML

Earnings Per Share (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Earnings per common share - Basic
Net income attributable to OBCI	$ 770,618	$ 1,137,685	$ 1,497,922	$ 2,175,382
Weighted average number of common shares outstanding	8,288,613	7,997,613	8,201,376	7,916,932
Earnings per common share – basic	$ 0.09	$ 0.14	$ 0.18	$ 0.27
Earnings per common share – Diluted
Net income attributable to OBCI	$ 770,618	$ 1,137,685	$ 1,497,922	$ 2,175,382
Weighted average number of common shares outstanding	8,288,613	7,997,613	8,201,376	7,916,932
Effect of employee stock-based awards	306,893	540,193	339,401	477,481
Weighted average number of common shares outstanding - assuming dilution	8,595,506	8,537,806	8,540,777	8,394,413
Earnings per common share – diluted	$ 0.09	$ 0.13	$ 0.18	$ 0.26
Earnings Per Share (Textual)
Anti-dilutive stock options outstanding	0	0	0	0

XML

Long Term Debt (Tables)

9 Months Ended

Sep. 30, 2012

Revolving Line Of Credit and Long Term Debt [Abstract]

Company’s long term debt

	Current Portion				Long Term Portion
	September 30,  2012		December 31, 2011		September 30,  2012		December 31, 2011
Term loan		385,652		375,562		1,611,316		1,901,830
Capitalized equipment leases		18,619		24,868		23,590		37,532
Total long term debt	$	404,271	$	400,430	$	1,634,906	$	1,939,362

Principal payments under Company’s long term obligations

12 month period ending September 30,
2013	$	404,271
2014		412,786
2015		423,384
2016		429,645
2017		369,091
Total	$	2,039,177

XML

Property, Plant, & Equipment (Details) (USD $)			9 Months Ended
	Sep. 30, 2012	Dec. 31, 2011	Sep. 30, 2012 Building and Improvements [Member]	Sep. 30, 2012 Manufacturing and warehouse equipment [Member] Minimum [Member]	Sep. 30, 2012 Manufacturing and warehouse equipment [Member] Maximum [Member]	Sep. 30, 2012 Office equipment and furniture [Member] Minimum [Member]	Sep. 30, 2012 Office equipment and furniture [Member] Maximum [Member]	Sep. 30, 2012 Leasehold improvements [Member] Minimum [Member]	Sep. 30, 2012 Leasehold improvements [Member] Maximum [Member]
Summary of property plant and equipment
Land	$ 278,325	$ 278,325
Building and improvements	4,487,267	4,445,924
Manufacturing and warehouse equipment	7,918,239	7,632,398
Office equipment and furniture	703,537	668,046
Construction in process	31,207	32,788
Leasehold improvements	122,644	122,644
Property, plant and equipment, gross	13,541,219	13,180,125
Less accumulated depreciation	(8,440,529)	(7,966,792)
Property, plant and equipment, net	$ 5,100,690	$ 5,213,333
Estimated Useful Life			30 years	6 years	20 years	3 years	5 years	10 years	15 years

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Condensed Consolidated Statement Of Comprehensive Income [Abstract]
Net income	$ 760,889	$ 1,128,139	$ 1,468,754	$ 2,132,665
Foreign currency translation adjustment	6,838	(3,759)	6,356	212
Comprehensive income	767,727	1,124,380	1,475,110	2,132,877
Comprehensive loss attributable to noncontrolling interests	9,729	9,546	29,168	42,717
Comprehensive income attributable to Ocean Bio-Chem, Inc.	$ 777,456	$ 1,133,926	$ 1,504,278	$ 2,175,594

XML

Property, Plant, & Equipment

9 Months Ended

Sep. 30, 2012

Property, Plant and Equipment [Abstract]

PROPERTY, PLANT, & EQUIPMENT

4. PROPERTY, PLANT, & EQUIPMENT

The Company’s property, plant and equipment consisted of the following at September 30, 2012 and December 31, 2011:

	Estimate Useful Life	September 30,  2012			December 31, 2011
Land		$	278,325		$	278,325
Building and improvements	30 years		4,487,267			4,445,924
Manufacturing and warehouse equipment	6-20 years		7,918,239			7,632,398
Office equipment and furniture	3-5 years		703,537			668,046
Construction in process			31,207			32,788
Leasehold improvements	10-15 years		122,644			122,644
Property, plant and equipment, gross			13,541,219			13,180,125
Less accumulated depreciation			(8,440,529	)		(7,966,792	)
Property, plant and equipment, net		$	5,100,690		$	5,213,333

XML

Noncontrolling Interest (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011
Noncontrolling Interest (Textual)
Assets	$ 23,187,511		$ 23,187,511		$ 19,878,756
Liabilities	7,324,000		7,324,000		5,845,178
Operating losses	1,175,231	1,628,396	2,415,546	3,308,598
OdorStar [Member]
Noncontrolling Interest (Textual)
Assets	507,000		507,000		541,000
Liabilities	7,000		7,000		6,000
Operating losses	$ 19,000	$ 19,000	$ 58,000	$ 85,000

XML

Property, Plant, & Equipment (Tables)

9 Months Ended

Sep. 30, 2012

Property, Plant and Equipment [Abstract]

Company’s property, plant and equipment

	Estimate Useful Life	September 30,  2012			December 31, 2011
Land		$	278,325		$	278,325
Building and improvements	30 years		4,487,267			4,445,924
Manufacturing and warehouse equipment	6-20 years		7,918,239			7,632,398
Office equipment and furniture	3-5 years		703,537			668,046
Construction in process			31,207			32,788
Leasehold improvements	10-15 years		122,644			122,644
Property, plant and equipment, gross			13,541,219			13,180,125
Less accumulated depreciation			(8,440,529	)		(7,966,792	)
Property, plant and equipment, net		$	5,100,690		$	5,213,333